Back to search

Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung

Data up to Jan 2025

Published1986
Citations30
References41

Total Citations Per Year

Abstract

References (41)

Interleukin 1, a potential regulator of fibroblast proliferation.

1982 • 835 citations

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1984 • 687 citations

Human natural killer cells: biologic and pathologic aspects.

1984 • 419 citations

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.

1984 • 371 citations

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.

1981 • 317 citations

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1984 • 299 citations

A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous Melanoma

1982 • 282 citations

Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins

1977 • 217 citations

Human large granular lymphocytes are potent producers of interleukin-1

1984 • 212 citations

The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.

1984 • 156 citations

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.

1983 • 123 citations

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.

1981 • 118 citations

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

1984 • 116 citations

Lymphokines: their role in lymphocyte responses. Properties of interleukin 1.

1982 • 113 citations

Primary but not metastatic human melanomas expressing dr antigens stimulate autologous lymphocytes

1984 • 104 citations

HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.

1984 • 96 citations

Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation.

1982 • 96 citations

Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.

1981 • 94 citations

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.

1984 • 93 citations

Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells

1978 • 92 citations

Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

1982 • 85 citations

Depressed Levels of Granular Lymphocytes with Natural Killer (NK) Cell Function in 247 Cancer Patients

1983 • 76 citations

Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations

1984 • 69 citations

Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture

1983 • 63 citations

Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.

1982 • 62 citations

The Potential role of T cells in cancer therapy

1982 • 60 citations

Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course

1983 • 55 citations

A Randomized Trial of Levamisole versus Placebo as Adjuvant Therapy in Malignant Melanoma

1980 • 54 citations

Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.

1980 • 52 citations

T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients.

1980 • 50 citations

Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course

1983 • 46 citations

Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population.

1982 • 38 citations

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes

1982 • 34 citations

Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma

1985 • 22 citations

Alloreactivity and Tumor Antigens: Generation of Syngeneic Antilymphoma Killer Lymphocytes by Alloimmunization of Mice With Normal Cells<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>

1983 • 20 citations

Passive adoptive immunotherapy of low‐immunogenic BALB/C lymphoma by syngeneic alloimmune T lymphocytes

1984 • 17 citations

Influence of human interferon-? therapy on cytotoxic functions of blood lymphocytes

1983 • 15 citations

Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes

1983 • 11 citations

Inhibition of Human Melanoma Growth in Nude Mice by Autologous, Alloactivated Peripheral Blood Lymphocytes

1984 • 11 citations

Perusing the ASCO abstracts with a focus on interferons in malignant melanoma and renal cell carcinoma

1984 • 5 citations

Interferon production and tumor cell killing by human lymphocytes stimulated in mixed-lymphocyte culture

1984 • 4 citations

Cited By (0)

No citing papers found in database

Systemic administration of autologous, alloactivated helper-enriched lymphocytes to… (1986) – Cancer Immunology Immunotherapy | Metascience Observatory Explorer